These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14134)

  • 21. Infantile Gaucher's disease: glucocerebrosidase deficiency in peripheral blood leukocytes and cultured fibroblasts.
    Sengers RC; Lamers KJ; Bakkeren JA; Schretlen ED; Trijbels JM
    Neuropadiatrie; 1975 Nov; 6(4):377-82. PubMed ID: 241947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between the two immunologically distinguishable forms of glucocerebrosidase in tissue extracts.
    Aerts JM; Donker-Koopman WE; van Laar C; Brul S; Murray GJ; Wenger DA; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1987 Mar; 163(3):583-9. PubMed ID: 3830174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple forms of membrane-bound beta-glucosidase in Gaucher's disease.
    Yaqoob M; Carroll M
    Clin Genet; 1981 Aug; 20(2):161-7. PubMed ID: 6796311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.
    Mikhaylova M; Wiederschain G; Mikhaylov V; Aerts JM
    Biochim Biophys Acta; 1996 Oct; 1317(1):71-9. PubMed ID: 8876629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites.
    Osiecki-Newman K; Fabbro D; Legler G; Desnick RJ; Grabowski GA
    Biochim Biophys Acta; 1987 Sep; 915(1):87-100. PubMed ID: 2956992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identity of 'acid' beta-glucosidase and glucocerebrosidase in human spleen.
    Ho MW
    Biochem J; 1973 Nov; 136(3):721-9. PubMed ID: 4780697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrolytic and transglucolytic activities of a partially purified calf brain beta-glucosidase.
    Mumford RA; Raghavan SS; Kanfer JN
    J Neurochem; 1976 Oct; 27(4):943-8. PubMed ID: 184255
    [No Abstract]   [Full Text] [Related]  

  • 28. Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity.
    Sasagasako N; Kobayashi T; Yamaguchi Y; Shinnoh N; Goto I
    J Biochem; 1994 Jan; 115(1):113-9. PubMed ID: 8188616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen.
    Aerts JM; Donker-Koopman WE; van der Vliet MK; Jonsson LM; Ginns EI; Murray GJ; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1985 Aug; 150(3):565-74. PubMed ID: 4018098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of detergents and choline-containing phospholipids on human spleen glucocerebrosidase.
    Blonder E; Klibansky C; de Vries A
    Biochim Biophys Acta; 1976 Apr; 431(1):45-53. PubMed ID: 1268244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease.
    Wenger DA; Clark C; Sattler M; Wharton C
    Clin Genet; 1978 Feb; 13(2):145-53. PubMed ID: 23912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
    Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate.
    Peters SP; Coyle P; Glew RH
    Arch Biochem Biophys; 1976 Aug; 175(2):569-82. PubMed ID: 958319
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.
    Grabowski GA; Goldblatt J; Dinur T; Kruse J; Svennerholm L; Gatt S; Desnick RJ
    Am J Med Genet; 1985 Jul; 21(3):529-49. PubMed ID: 3927728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease.
    Ben-Yoseph Y; Nadler HL
    J Clin Pathol; 1978 Nov; 31(11):1091-3. PubMed ID: 105017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the molecular defect in infantile and adult acid alpha-glucosidase deficiency fibroblasts.
    Beratis NG; LaBadie GU; Hirschhorn K
    J Clin Invest; 1978 Dec; 62(6):1264-74. PubMed ID: 34626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
    Choy FY
    Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites.
    Grabowski GA; Gatt S; Kruse J; Desnick RJ
    Arch Biochem Biophys; 1984 May; 231(1):144-57. PubMed ID: 6426391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease.
    Daniels LB; Glew RH; Diven WF; Lee RE; Radin NS
    Clin Chim Acta; 1981 Sep; 115(3):369-75. PubMed ID: 6794954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophoretic separation of neutral and acid beta-glucosidase isozymes in human tissues.
    Shafit-Zagardo B; Devine EA; Desnick RJ
    Biochim Biophys Acta; 1980 Aug; 614(2):459-65. PubMed ID: 6773581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.